20-Sep-2021 | Market Research Store

The MRS report titled “Adiponectin Testing Market By Product Type (ELISA Testing, Enzyme Immunoassay Testing, and Others), By Application (Hospital, Specialty Clinics, Diagnostics Laboratories, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2021–2026” states that the global demand for the adiponectin testing market in 2020 was approximately USD 1,905.2 Million. The market is expected to grow at a CAGR of 5.6% and is anticipated to reach around USD 2,600.6 Million by 2026.

Adiponectin has a shown major clinical perspective as an adipocyte-derived protein in the pathophysiology of metabolic diseases and coronary artery disease. Advanced level of circulating adiponectin is associated with the high risk of pre-diabetes, metabolic syndrome, and adverse cardiovascular events. In addition, the health care industry has also focused on gaining from the testing on animals where the insulin-sensitizing, antiatherogenic, anti-inflammatory, cardiomyocyte-protective properties of the hormone are used. The major application area of adiponectin testing is for diagnostics and research. The procedures used consist of enzyme-linked immunosorbent assay (ELISA) and enzyme immunoassay kits.

Recently, drug manufacturers have been aiming at new drug targets for insulin resistance (IR)-a related metabolic disorder which is driving the industry interest in adiponectin testing. Moreover, the ever-increasing demand for the population for the diagnosis of hypoadiponectinemia has stimulated the prospect of the adiponectin testing market. Also, the increasing epidemic of obese populations of all ages has also been boosting the clinical studies on adiponectin levels in the body. 

On the other hand, the introduction of useful food ingredients that affirm to progress adipocyte health and adiponectin metabolism has escalated the opportunities for manufacturers. Many years back, studies those focus on the meta-analysis of the hormone as a biomarker for the diagnosis of metabolic syndrome have gained steam, thus enhancing the adiponectin testing market. Latest advancements in lab infrastructure for such tests are driving the investment in the adiponectin testing market. Furthermore, market players of testing kits are determined to increase their manufactured goods portfolio in the adiponectin testing market, and several have set foot into the latest product launches and investments. Also, they have assembled scientific backing that is based on a meta-analysis of the clinical perspective of adiponectin.

Browse the full Adiponectin Testing Market By Product Type (ELISA Testing, Enzyme Immunoassay Testing, and Others), By Application (Hospital, Specialty Clinics, Diagnostics Laboratories, and Others): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026.” Report at https://www.marketresearchstore.com/market-insights/adiponectin-testing-market-828627

Geographically, North America is accounted for the biggest share in the global adiponectin testing market due to the rising potential of adipose-based products in reinforcing the drug pipelines for the treatment of the metabolic syndrome. Likewise, Asia-Pacific regions with expanding medical tourism have been showing vast potential in the adiponectin testing market which is expected to increase the market growth during the forecast period.

Some major players in the global adiponectin testing market are Stratec SE, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Eagle Biosciences, Boster Biological Technology, and LabCorp.

For example, STRATEC SE is a company with worldwide operations that develops and produces analyzer systems and automation systems in the field of in-vitro-diagnostics. In March 2016, STRATEC acquired the Hungary-based company Diatron, a hematology system specialist. The company develops and manufactures analyzer systems and complementary products for use in human and veterinary diagnostics.

This report segments the global adiponectin testing market as follows:

Global Adiponectin Testing Market: By Type

  • ELISA Testing
  • Enzyme Immunoassay Testing
  • Others

Global Adiponectin Testing Market: By Application

  • Hospital
  • Specialty Clinics
  • Diagnostics Laboratories
  • Others

Global Adiponectin Testing Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Market Research Store is a single destination for all types of industries, global, and regional reports. We feature large repository of latest industry reports and market statistics published by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available. Our vast database of reports enables our clients to benefit from expert insights on global industries, products, and market trends.

Contact Us:

Market Research Store
244 Fifth Avenue, Suite N202
New York, 10001, United States
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@MarketResearchStore.com
Website: https://www.marketresearchstore.com